16th Biosimilars Congregation 2021

The global biosimilars market size is expected to grow from USD 35.7 billion by 2025 from USD 11.8 billion in 2020, at a CAGR of 24.7%.

However, with complexities in manufacturing and resistance from biologic manufacturers, such factors keep adding to the hindrance in their development.

2030, India will become the sixth-largest market for pharmaceuticals, and it has firmly established itself in the global biopharmaceutical market. Many of the Indian pharmaceutical companies are preparing to step into the global biosimilars market. As per the report of 2017, biosimilars represent a 30% compound annual growth rate. They are worth $2.2bn out of the $32bn total Indian pharma market and are estimated to reach $40bn by the year 2030.

Virtue Insight is delighted to invite you to attend the 16th Biosimilars Congregation 2021 conference, to be held on 09th December 2021(Virtual Conference). 16th Biosimilars Congregation 2021 brings together scientists, researchers and CROs from around the world.

At 16th Biosimilars Congregation 2021 meet your target audiences from around the world focused on learning about biologics and biosimilars. This conference would be your single best opportunity to reach the largest assemblage of participants from the biologics and biosimilars community